KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Income from Non-Controlling Interests (2017 - 2020)

BeOne Medicines (ONC) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with $96000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Income from Non-Controlling Interests fell 42.17% to $96000.0 in Q4 2020 year-over-year; TTM through Dec 2021 was -$1.3 million, a 64.14% increase, with the full-year FY2020 number at -$3.6 million, down 85.49% from a year prior.
  • Income from Non-Controlling Interests was $96000.0 for Q4 2020 at BeOne Medicines, up from -$1.4 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1.5 million in Q4 2018 to a low of -$1.4 million in Q3 2020.
  • A 4-year average of -$401666.7 and a median of -$429000.0 in 2019 define the central range for Income from Non-Controlling Interests.
  • Biggest YoY gain for Income from Non-Controlling Interests was 3493.02% in 2018; the steepest drop was 513.33% in 2018.
  • BeOne Medicines' Income from Non-Controlling Interests stood at $43000.0 in 2017, then soared by 3493.02% to $1.5 million in 2018, then plummeted by 89.26% to $166000.0 in 2019, then tumbled by 42.17% to $96000.0 in 2020.
  • Per Business Quant, the three most recent readings for ONC's Income from Non-Controlling Interests are $96000.0 (Q4 2020), -$1.4 million (Q3 2020), and -$1.1 million (Q2 2020).